METHOD FOR TREATMENT OF PATIENTS WITH ULCERATIVE COLLITIS USING ALFAZOX Russian patent published in 2021 - IPC A61K31/245 A61K31/57 A61K31/728 A61K31/79 A61P1/04 

FIELD: medicine.

SUBSTANCE: invention relates to medicine, namely to surgery and gastroenterology, and for the treatment of patients with ulcerative colitis. For this, in addition to the first-line drugs - mesalazine 1-2 g / day in the form of suppositories and budesonide 2 mg / day in the form of rectal foam, the drug Alfazox is administered. 1 sachet containing 10 ml of Alfazox is mixed with 15 ml of 0.9% sterile NaCl solution. The prepared suspension is administered rectally by microclysters, twice a day for 14 days.

EFFECT: method provides for increased efficiency and decreased duration of treatment due to the protective effect of the complex of drugs on the mucous membrane, which helps to reduce inflammation and the healing of ulcerative and erosive defects.

1 cl; 2 ex